另据《卫报》报道，在诸多未成功的出价人当中，以直言不讳著称的无神论者、牛津大学进化生物学家理查德·道金斯赫然在列。
Among the unsuccessful bidders, according to the Guardian newspaper, was Oxford evolutionary biologist Richard Dawkins, an outspoken atheist.
格列卫（Gleevec）这种广为宣传的抗白血病药物在这里成了现代基因癌症治疗的英雄，是一种“理性设计”出来专门针对特定肿瘤基因的药物。
The much touted anti-leukemia drug Gleevec here appears as the hero of modern, genetics-based cancer therapy, a “rationally designed” drug specifically directed against a known cancer gene.
最新研究表明新的靶向治疗药物SU11248对格列卫耐药的患者有延长生存期的作用。
Recent research shows that a new targeting therapeutic agent, SU11248, can prolong the survival time of the patients with GISTs who were resistant to Gleevec therapy.
这里说，格列卫专利保护期，包括对药物成分和生产工艺的保护，长达20年。
Under the Trade Related Intellectual Property Rights act, patents for drugs, including the ingredients for the drugs and manufacturing procedures, are protected for up to 20 years .
而格列卫，来自于慢性髓细胞性白血病的药物。Vogelstein说：“我们的工作提示大多数实体肿瘤实际上不同于CML。”
While Gleevec, a pill, transformed the treatment of a blood cancer called chronic myeloid leukemia, "our work suggests that most solid tumors are really nothing like CML," Vogelstein said.
而格列卫，来自于慢性髓细胞性白血病的药物。Vogelstein说：“我们的工作提示大多数实体肿瘤实际上不同于CML。”
While Gleevec, a pill, transformed the treatment of a blood cancer called chronic myeloid leukemia, "our work suggests that most solid tumors are really nothing like CML," Vogelstein said.
应用推荐